Loading…

Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy

End stage (ES) is a recognized part of the hypertrophic cardiomyopathy (HCM) disease spectrum. Frequency, clinical profile and course, and treatment strategies in these patients remain incompletely defined. Three HCM cohorts comprised 1259 patients, including 44 (3.5%) characterized as ES with systo...

Full description

Saved in:
Bibliographic Details
Published in:Circulation (New York, N.Y.) N.Y.), 2006-07, Vol.114 (3), p.216-225
Main Authors: HARRIS, Kevin M, SPIRITO, Paolo, MARON, Martin S, ZENOVICH, Andrey G, FORMISANO, Francesco, LESSER, John R, MACKEY-BOJACK, Shannon, MANNING, Warren J, UDELSON, James E, MARON, Barry J
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:End stage (ES) is a recognized part of the hypertrophic cardiomyopathy (HCM) disease spectrum. Frequency, clinical profile and course, and treatment strategies in these patients remain incompletely defined. Three HCM cohorts comprised 1259 patients, including 44 (3.5%) characterized as ES with systolic dysfunction (ejection fraction
ISSN:0009-7322
1524-4539
DOI:10.1161/CIRCULATIONAHA.105.583500